Breaking News

BioFocus, Aviva Ink Lab Pact

September 3, 2013

To build 60,000-sq.-ft. lab at Chesterford Research Park

BioFocus has signed a pre-let agreement with Aviva Investors for the new Robinson Building, a 60,000-sq.-ft. lab facility at Chesterford Research Park near Cambridge, UK. BioFocus will combine the majority of its drug discovery groups in the new complex to support integrated projects. The Robinson Building has outline planning permission and construction is expected to begin immediately.
Chris Newton, managing director of BioFocus, said, “BioFocus has been expanding its research activities at Chesterford Park, bringing our expertise in different areas such as structural biology, complex cell assays, and medicinal chemistry closer together.  Moving many of these teams into a single, modern and efficient building is an important step forward for the company and will bring added synergies to both our business model and to our scientists.”
Julian Cobourne, asset manager for Aviva Investors, said, “Chesterford Research Park has provided significant support to BioFocus in meeting its property needs over the years and it has been great to work with them to design a much more efficient laboratory building to meet their future requirements.”
blog comments powered by Disqus
  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity